Program Committee

Lynn Bass

J. Lynn Bass, PharmD, RPh, Jazz Pharmaceuticals


Daniel Bollag

Daniel Bollag, PhD, Ariad Pharmaceuticals, Inc.


Linda Bowen

Linda Bowen, MS, RAC, Sanofi


Jonca Bull

Jonca Bull, MD, Office of the Commissioner, FDA


Bill Byrom

Bill Byrom, PhD, Consultant


Joy Cavagnaro

Joy Cavagnaro, PhD, RAC, Access BIO


Karla Childers

Karla Childers, MS, Johnson & Johnson


Leah Christl

Leah Christl, PhD, CDER, FDA


Betsy Fallen

Betsy Fallen, RN, BAFallen Consulting, LLC


Ron Fitzmartin

Ron Fitzmartin, PhD, MBA, CDER, FDA


Michael Folkendt

Michael Folkendt, MS, CDER, FDA


Garrard Elizabeth

Elizabeth Garrard, PharmD, RPh, United Therapeutics Corporation


Jonathan Haddad

Jonathan Haddad, MPH, MT, GlaxoSmithKline


Martin Harvey-Allchurch

Martin Harvey Allchurch, LLM, European Medicines Agency, European Union


Jonathan Helfgott

Jonathan Helfgott, MS, Stage 2 Innovations

 
Deborah Henderson

Deborah Henderson, MSN, Merck & Co., Inc


Rima Izem

Rima Izem, PhD, CDER, FDA


Janet Jenkins-Showalter

Janet Jenkins-Showalter, Genentech, A Member of the Roche Group


John Kamp

John Kamp, JD, PhD, Wiley Rein LLP; Coalition for Healthcare Communication


Ellen Kelso

Ellen Kelso, Chesapeake IRB


 
Lisa Kim

Lisa Palladino Kim, MS, Rutgers, The State University of New Jersey

 
Lynn King

Lynn King, MHA, TKL Research

 
Agnes Kein

Agnes Klein, DrPH, MD, Health Canada

 
Stephen Knowles

Stephen Knowles, MD, MRCP, Eli Lilly and Company

 
Mark Kryah

Mark Kryah, PMP, Eli Lilly and Company


Jean-Marie Markham

Jean Marie Markham, Clinlogix LLC


Philomena McArthur

Philomena McArthur, JD, Johnson & Johnson International


Ann Oconnell

Ann Meeker-O'Connell, MS, Janssen Pharmaceuticals, Inc.

 
Jon Meyer

Jon Meyer, MBA, MSc, Life Science Strategy Group, LLC


Mary Murray

Mary Murray, MBA, Bristol-Myers Squibb Company


 
Bob Muzerall

Bob Muzerall, ForeignExchange Translations


Nancy Myers

Nancy Myers, JD, Catalyst Healthcare Consulting, Inc


Jane Myles

Jane Myles, MS, Genentech, A Member of the Roche Group

 
Roger Nosal

Roger Nosal, MA, MS, Pfizer Inc

 
Paul Pradip

Pradip Paul, MD, MS, Strategic Pharmacovigilance and Risk Management

 
Kirsten Paulson

Kirsten Paulson, MS, RAC, Pfizer Inc

 
Julia Petses

Julia Petses, PharmD, Sanofi

 
Christine Pierre

Christine Pierre, RN, Society for Clinical Research Sites

 
Jim Polli

James Polli, PhD, University of Maryland School of Pharmacy

 
Sarah Pope Miksinski

Sarah Pope Miksinski, PhD, CDER, FDA


Badri Rengarajan

Badri Rengarajaran, MD, International Pemphigus and Pemphigoid Foundation


Matthew Rotelli

Matthew Rotelli, PhD, Eli Lilly and Company


Sam Leslie

Leslie Sam, Eli Lilly and Company


Abdul Sankoh

Abdul Sankoh, PhD, MA, MS, Synageva Biopharma


Suzanne Sensabaugh

Suzanne Sensabaugh, Hartmann Willner LLC



Ashley Slagle PhD, MS, CDER, FDA


Nancy Smerkanich

Nancy Smerkanich, MSc, University of Southern California


Maureen Smith

Maureen Smith, MEd, Canadian Organization for Rare Disorders (CORD)


William Smith

William Smith, MD, New Orleans Center For Clinical Research and Volunteer Research Group


Ling Su

Ling Su, PhD, Sidley Austin LLP, China


Sameer Thapur

Sameer Thapar, PharmD, Rutgers, The State University of New Jersey


Toshi Tominaga

Toshiyoshi Tominaga, PhD, Pharmaceuticals and Medical Devices Agency (PMDA)


Linda Wood

Linda Wood, MPH, RN, MedWrite, Inc.